Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
[
Title
]
Type
Year
Filters:
Author
is
Avet-Loiseau, Hervé
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
C
Di Bacco A
,
Bahlis NJ
,
Munshi NC
,
Avet-Loiseau H
,
Masszi T
,
Viterbo L
,
Pour L
,
Ganly P
,
Cavo M
,
Langer C
, et al.
c-MYC expression and maturity phenotypes are associated with outcome benefit from addition of ixazomib to lenalidomide-dexamethasone in myeloma.
Eur J Haematol. 2020.
PubMed
Google Scholar
D
Touzeau C
,
Perrot A
,
Hulin C
,
Manier S
,
Macro M
,
Chrétien M-L
,
Karlin L
,
Escoffre M
,
Jacquet C
,
Tiab M
, et al.
Daratumumab Carfilzomib Lenalidomide and Dexamethasone with tandem transplant in high-risk newly diagnosed myeloma.
Blood. 2024.
PubMed
Google Scholar
E
Caulier A
,
Roussel M
,
Morel P
,
Lombion N
,
Branco B
,
Galtier J
,
Hulin C
,
Perrot A
,
Richez V
,
Michaud-Robert A-V
, et al.
EPIDEMIOLOGICAL LANDSCAPE OF YOUNG MULTIPLE MYELOMA PATIENTS DIAGNOSED EARLIER THAN 40 YEARS: THE FRENCH EXPERIENCE.
Blood. 2021.
PubMed
Google Scholar
Avet-Loiseau H
,
San-Miguel J
,
Casneuf T
,
Iida S
,
Lonial S
,
Usmani SZ
,
Spencer A
,
Moreau P
,
Plesner T
,
Weisel K
, et al.
Evaluation of Sustained Minimal Residual Disease Negativity With Daratumumab-Combination Regimens in Relapsed and/or Refractory Multiple Myeloma: Analysis of POLLUX and CASTOR.
J Clin Oncol. 2021:JCO2001814.
PubMed
Google Scholar
F
Botta C
,
Maia CDa Silva
,
Garcés J-J
,
Termini R
,
Perez C
,
Manrique I
,
Burgos L
,
Zabaleta A
,
Alignani D
,
Sarvide S
, et al.
FlowCT for the analysis of large immunophenotypic datasets and biomarker discovery in cancer immunology.
Blood Adv. 2021.
PubMed
Google Scholar
G
Samur MKemal
,
Samur AAktas
,
Fulciniti M
,
Szalat R
,
Han T
,
Shammas M
,
Richardson P
,
Magrangeas F
,
Minvielle S
,
Corre J
, et al.
Genome-Wide Somatic Alterations in Multiple Myeloma Reveal a Superior Outcome Group.
J Clin Oncol. 2020:JCO2000461.
PubMed
Google Scholar
H
Beaussant Y
,
Daguindau E
,
Pugin A
,
Mohty M
,
Avet-Loiseau H
,
Roos-Weil D
,
Michallet M
,
Chevalier P
,
Raus N
,
El-Cheikh J
, et al.
Hematopoietic stem cell transplantation in multiple myeloma. A retrospective study of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
Biol Blood Marrow Transplant. 2015.
PubMed
Google Scholar
L
Benboubker L
,
Dimopoulos MA
,
Dispenzieri A
,
Catalano J
,
Belch AR
,
Cavo M
,
Pinto A
,
Weisel K
,
Ludwig H
,
Bahlis N
, et al.
Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma.
N Engl J Med. 2014;371(10):906-917.
PubMed
Google Scholar